ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,257Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 324

$686K Total Retail Price of All Prescriptions

Rank: 46 out of 324

534 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
7% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 534 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 534 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 10,762 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 897 852 1 1
AMLODIPINE BESYLATE 447 427 2 4
HYDROCHLOROTHIAZIDE 411 389 3 11
LISINOPRIL 394 387 4 3
ATORVASTATIN CALCIUM 393 372 5 12
LOSARTAN POTASSIUM 366 342 6 15
LEVOTHYROXINE SODIUM 328 320 7 2
POTASSIUM CHLORIDE 294 279 8 8
OMEPRAZOLE 272 272 9 6
ZOLPIDEM TARTRATE 253 251 10 20
ALENDRONATE SODIUM 210 200 11 24
METFORMIN HCL 194 189 12 9
WARFARIN SODIUM 192 192 13 10
CITALOPRAM HBR 180 157 14 16
METOPROLOL SUCCINATE 178 176 15 17
FUROSEMIDE 168 168 16 7
HYDROCODONE-ACETAMINOPHEN 143 136 S3 17 5
CARVEDILOL 135 135 18 22
GABAPENTIN 131 116 19 13
NAMENDA 131 131 19 31
ALLOPURINOL 113 113 21 27
CRESTOR 113 112 21 28
MELOXICAM 111 109 23 29
TRAMADOL HCL 107 107 24 19
JANUVIA 97 96 25 83
SERTRALINE HCL 92 91 26 23
DILTIAZEM 24HR CD 91 91 27 81
SYNTHROID 91 91 27 30
VYTORIN 87 87 29 140
DONEPEZIL HCL 83 83 30 25
METOPROLOL TARTRATE 80 79 31 14
LOSARTAN-HYDROCHLOROTHIAZIDE 75 63 32 44
PAROXETINE HCL 70 60 33 72
TAMSULOSIN HCL 67 52 34 26
BYSTOLIC 66 66 35 111
ATENOLOL 66 66 35 18
ZETIA 66 63 35 68
CELEBREX 65 65 38 96
LOVASTATIN 65 65 38 43
PROAIR HFA 65 63 38 50
TRIAMTERENE-HCTZ 63 63 41 46
CIPROFLOXACIN HCL 62 60 42 55
CEPHALEXIN 62 58 42 90
QUINAPRIL HCL 61 59 44 186
OXYCONTIN 58 58 S2 45 108
LIPITOR 58 58 45 109
DETROL LA 57 57 47 155
TERAZOSIN HCL 57 57 47 133
ADVAIR DISKUS 54 54 49 61
FLUTICASONE PROPIONATE 52 51 50 32
OXYCODONE-ACETAMINOPHEN 51 50 S2 51 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.